squeak1,
The only nonsense I've seen is the continued drop in the stock price and my ultimate loss of $4,000. The only way I could have recovered my losses was to get lucky and buy low when the RS occurred and time the sell right after the pump. The shares I have from before I can't sell and are still listed at 0.0001 on my Scottrade account. The company and CTLM are going nowhere IMO. There are other "adjunct" diagnostic methods approved by the FDA like Digital Tomosynthesis and somo-v ABUS (a breast ultrasound imaging system for dense breast tissue to assist the clinician in identifying small tumors). I mentioned this in previous posts. It appears that not only is IMDS managed by crooks but the competition is scooping them. I have to agree with others who have outlined IMDS and CTLM's 19 year history with little success. Those are the facts and it seems a big stretch to blame the FDA process and crooked lobbyists, etc for their failures. Color me stupid for buying into IMDS and not doing my homework. C
News 
Market Data 
Discover 
AI
